Similar articles

• Clinical laboratory experiences with a more attenuated Enders' measles virus vaccine (Moraten) combined with smallpox vaccine.

  Weibel RE, Stokes J Jr, Buynak EB, Leagus MB, Hilleman MR. Weibel RE, et al. Pediatrics. 1969 Apr;43(4):567-72. Pediatrics. 1969. PMID: 4304934 No abstract available.
• Field evaluation of combined more attenuated live measles (Moraten)-smallpox vaccine in Honduras and Costa Rica.

  Villarejos VM, Rodríguez-Aragonés A, Gúnera N, Arguedas JA, Buynak EB, Hilleman MR. Villarejos VM, et al. Am J Epidemiol. 1971 May;93(5):384-91. doi: 10.1093/oxfordjournals.aje.a121271. Am J Epidemiol. 1971. PMID: 5556398 No abstract available.
• [Development of measles vaccination in Austria].

  Huber EG, Rannon L. Huber EG, et al. Padiatr Padol. 1973;8(3):247-56. Padiatr Padol. 1973. PMID: 4715034 German. No abstract available.
• Measles immunity and immunization in developing countries of Africa: a review.

  Abdurrahman MB, Taqi AM. Abdurrahman MB, et al. Afr J Med Med Sci. 1981 Mar-Jun;10(1-2):57-62. Afr J Med Med Sci. 1981. PMID: 6287828 Review.
• [Results of a trial of an erythrocyte measles diagnostic agent in public health institutions].

  Polzik TP, Kashkina GB, Andrianova DP, Bol'shakova SL, Petrova MA. Polzik TP, et al. Tr Inst Im Pastera. 1981;56:112-4. Tr Inst Im Pastera. 1981. PMID: 6764964 Review. Russian. No abstract available.